About Adaptive Biotechnologies Adaptive Biotechnologies is a commercial-stage biotechnology company focused on translating the genetic language of the adaptive immune system into clinical products to diagnose and treat disease. Quick Links Stock Governance Filings Press Releases Adaptive Biotechnologies to Present New SARS-CoV-2 Data from its Immune Medicine Platform During IDWeek 2021 09-16-2021 at 8:04 AM EDT Adaptive Biotechnologies to Present at the Morgan Stanley Global Healthcare Conference 09-07-2021 at 5:15 PM EDT Adaptive Biotechnologies Appoints Nitin Sood as Chief Commercial Officer 08-04-2021 at 4:15 PM EDT VIEW ALL NEWS Upcoming Events & Presentations More events are coming soon. Past Events & Presentations Morgan Stanley Global Healthcare Conference Sep 14, 2021 at 8:00 AM PDT Listen to webcast Adaptive Biotechnologies Second Quarter Financial Results Aug 4, 2021 at 4:30 PM EDT Listen to webcast Adaptive Biotechnologies Second Quarter Earnings Presentation 1.4 MB Annual Shareholder Meeting Jun 11, 2021 Listen to webcast VIEW ALL EVENTS CHANGE VOLUME 52 week high 52 week LOW MARKET CAP Sep 20, 2021 11:02 PM EDTData Provided by Refinitiv. Minimum 15 minutes delayed.
